NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

醫藥品原料藥 (API)的全球市場:各類型,各合成,各製造廠商,各治療用途的市場調查,預測(∼2025年),COVID-19的累積性的影響

Active Pharmaceutical Ingredient Market Research Report by Type, by Synthesis, by Manufacturer, by Therapeutic Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1005059
出版日期 內容資訊 英文 196 Pages
商品交期: 最快1-2個工作天內
價格
醫藥品原料藥 (API)的全球市場:各類型,各合成,各製造廠商,各治療用途的市場調查,預測(∼2025年),COVID-19的累積性的影響 Active Pharmaceutical Ingredient Market Research Report by Type, by Synthesis, by Manufacturer, by Therapeutic Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 196 Pages
簡介

全球醫藥品原料藥 (API的)市場規模預測將從2020年的1,886億2,878萬美元,擴大到2025年末的2,484億2,070萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

 

這份報告提供醫藥品原料藥 (API的)世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,類型·合成·廠商·治療用途·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 製造商預測
  • 治療用途預測
  • 類型預測
  • 合成預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各類型

  • 學名藥原料藥 (API)
  • 創新的醫藥品原料藥 (API)

第7章 各合成

  • 生物科技的有效成分
  • 合成有效成分

第8章 各製造廠商

  • 專屬式API廠商
  • 商人API廠商

第9章 各治療用途

  • 心血管疾病
  • 傳染病
  • 糖尿病
  • 腫瘤學
  • 疼痛管理
  • 呼吸疾病

第10章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章 歐洲,中東·非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第14章 企業的實用性簡介

  • Abbvie Inc.
  • API Pharma Tech
  • Astrazeneca
  • Aurobindo Pharma
  • BASF SE
  • BDR Pharmaceuticals Internationals Pvt. Ltd.
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cipla, Inc.
  • Dr. Reddy's Laboratories Ltd
  • ELI Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd

第15章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-430D42AA0F85

The Global Active Pharmaceutical Ingredient Market size was estimated at USD 188.62 Billion in 2020 and expected to reach USD 200.25 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 6.49% to reach USD 275.23 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Active Pharmaceutical Ingredient to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Active Pharmaceutical Ingredient Market was studied across Generic Active Pharmaceutical Ingredients and Innovative Active Pharmaceutical Ingredients.

Based on Synthesis, the Active Pharmaceutical Ingredient Market was studied across Biotech Active Pharmaceutical Ingredients and Synthetic Active Pharmaceutical Ingredients.

Based on Manufacturer, the Active Pharmaceutical Ingredient Market was studied across Captive API Manufacturers and Merchant API Manufacturers.

Based on Therapeutic Application, the Active Pharmaceutical Ingredient Market was studied across Cardiovascular Diseases, Communicable Diseases, Diabetes, Oncology, Pain Management, and Respiratory Diseases.

Based on Geography, the Active Pharmaceutical Ingredient Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Active Pharmaceutical Ingredient Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Active Pharmaceutical Ingredient Market, including Abbvie Inc., API Pharma Tech, Astrazeneca, Aurobindo Pharma, BASF SE, BDR Pharmaceuticals Internationals Pvt. Ltd., Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, Inc., Dr. Reddy's Laboratories Ltd, ELI Lilly and Company, F. Hoffmann-La Roche, Glaxosmithkline PLC, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Active Pharmaceutical Ingredient Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Active Pharmaceutical Ingredient Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Active Pharmaceutical Ingredient Market?
  • 4. What is the competitive strategic window for opportunities in the Global Active Pharmaceutical Ingredient Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Active Pharmaceutical Ingredient Market?
  • 6. What is the market share of the leading vendors in the Global Active Pharmaceutical Ingredient Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Active Pharmaceutical Ingredient Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Manufacturer Outlook
  • 3.4. Therapeutic Application Outlook
  • 3.5. Type Outlook
  • 3.6. Synthesis Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic diseases
      • 5.1.1.2. Growing importance of generics coupled with uptakes of biopharmaceuticals
      • 5.1.1.3. Technological advancements in active pharmaceutical ingredients
      • 5.1.1.4. Adoption of AI-based tools and organ-on-chip models in drug discovery & development
      • 5.1.1.5. Rising focus on precision medicine and growing investment
    • 5.1.2. Restraints
      • 5.1.2.1. Unsupportive price control policies for drug across various countries
      • 5.1.2.2. Increasing availability of counterfeit drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of biosimilars
      • 5.1.3.2. Highly effective active pharmaceutical ingredients
    • 5.1.4. Challenges
      • 5.1.4.1. High cost associated with the manufacturing process
      • 5.1.4.2. Concern associated with the product differentiation
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Active Pharmaceutical Ingredient Market, by Type

  • 6.1. Introduction
  • 6.2. Generic Active Pharmaceutical Ingredients
  • 6.3. Innovative Active Pharmaceutical Ingredients

7. Active Pharmaceutical Ingredient Market, by Synthesis

  • 7.1. Introduction
  • 7.2. Biotech Active Pharmaceutical Ingredients
  • 7.3. Synthetic Active Pharmaceutical Ingredients

8. Active Pharmaceutical Ingredient Market, by Manufacturer

  • 8.1. Introduction
  • 8.2. Captive API Manufacturers
  • 8.3. Merchant API Manufacturers

9. Active Pharmaceutical Ingredient Market, by Therapeutic Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Communicable Diseases
  • 9.4. Diabetes
  • 9.5. Oncology
  • 9.6. Pain Management
  • 9.7. Respiratory Diseases

10. Americas Active Pharmaceutical Ingredient Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Active Pharmaceutical Ingredient Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Active Pharmaceutical Ingredient Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbvie Inc.
  • 14.2. API Pharma Tech
  • 14.3. Astrazeneca
  • 14.4. Aurobindo Pharma
  • 14.5. BASF SE
  • 14.6. BDR Pharmaceuticals Internationals Pvt. Ltd.
  • 14.7. Boehringer Ingelheim
  • 14.8. Bristol-Myers Squibb
  • 14.9. Cipla, Inc.
  • 14.10. Dr. Reddy's Laboratories Ltd
  • 14.11. ELI Lilly and Company
  • 14.12. F. Hoffmann-La Roche
  • 14.13. Glaxosmithkline PLC
  • 14.14. Merck & Co., Inc.
  • 14.15. Mylan N.V.
  • 14.16. Novartis AG
  • 14.17. Pfizer, Inc.
  • 14.18. Sanofi
  • 14.19. Sun Pharmaceutical Industries Ltd
  • 14.20. Teva Pharmaceutical Industries Ltd

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2026
  • FIGURE 12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2026
  • FIGURE 19. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2020 VS 2026 (%)
  • FIGURE 24. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2026
  • FIGURE 26. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 VS 2026 (%)
  • FIGURE 31. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2026
  • FIGURE 33. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 46. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 48. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 61. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 63. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 74. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 82. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 83. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 84. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 85. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 86. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 87. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 11. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY CAPTIVE API MANUFACTURERS, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 19. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MERCHANT API MANUFACTURERS, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 21. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 23. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 25. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY COMMUNICABLE DISEASES, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 27. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY DIABETES, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 29. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY ONCOLOGY, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 31. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 33. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY RESPIRATORY DISEASES, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 35. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 37. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 39. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 41. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 43. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 45. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 47. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 49. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 51. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 53. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 55. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 57. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 59. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 61. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 63. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 65. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 67. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 69. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 71. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 73. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 75. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 77. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 79. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 81. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 83. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 85. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 87. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 89. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 91. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 93. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. CALIFORNIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 95. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 97. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 99. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 101. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. FLORIDA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 103. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 105. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 107. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 109. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. ILLINOIS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 111. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 113. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 115. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 117. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. NEW YORK ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 119. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 121. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 123. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 125. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 126. OHIO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 127. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 128. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 129. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 130. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 131. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 132. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 133. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 134. PENNSYLVANIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 135. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 136. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 137. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 138. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 139. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 140. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 141. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 142. TEXAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 143. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 144. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 145. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 146. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 147. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 148. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 149. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 150. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 151. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 152. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 153. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 154. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 155. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 156. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 157. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 158. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 159. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 160. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 161. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 162. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 163. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 164. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 165. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 166. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 167. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 168. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 169. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 170. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 171. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 172. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 173. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 174. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 175. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 176. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 177. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 178. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 179. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 180. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 181. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 182. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 183. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 184. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 185. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 186. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 187. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 188. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 189. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 190. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 191. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 192. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 193. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 194. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 195. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 196. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 197. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 198. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 199. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 200. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 201. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 202. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 203. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 204. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 205. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 206. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 207. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 208. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 209. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 210. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 211. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 212. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 213. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 214. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 215. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 216. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY GEOGRAPHY, 2018-2026 (KILOTON)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 227. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 228. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 229. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 230. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 231. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 232. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 233. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 234. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 235. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 236. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 237. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 238. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 239. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 240. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 241. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 242. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 243. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 244. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 245. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 246. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 247. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 248. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 249. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 250. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 251. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 252. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 253. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 254. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 255. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 256. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 257. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 258. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 259. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 260. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 261. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 262. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 263. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 264. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 265. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 266. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 267. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 268. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 269. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 270. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 271. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 272. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 273. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 274. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 275. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 276. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
  • TABLE 277. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 278. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
  • TABLE 279. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 280. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
  • TABLE 281. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 282. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
  • TABLE 283. SOUTH AFRICA ACTIVE